NO961207D0 - Tetrahydropyridin-(eller 4-hydroksypiperidin)-alkylazoler som har affinitet for sigma og/eller 5HT1A-reseptorer - Google Patents
Tetrahydropyridin-(eller 4-hydroksypiperidin)-alkylazoler som har affinitet for sigma og/eller 5HT1A-reseptorerInfo
- Publication number
- NO961207D0 NO961207D0 NO961207A NO961207A NO961207D0 NO 961207 D0 NO961207 D0 NO 961207D0 NO 961207 A NO961207 A NO 961207A NO 961207 A NO961207 A NO 961207A NO 961207 D0 NO961207 D0 NO 961207D0
- Authority
- NO
- Norway
- Prior art keywords
- hydroxypiperidine
- tetrahydropyridine
- sigma
- affinity
- 5ht1a receptors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D521/00—Heterocyclic compounds containing unspecified hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9409443A FR2723091B1 (fr) | 1994-07-29 | 1994-07-29 | Tetrahydropyridine-(6,4-hydroxypiperidine) alkylazoles |
PCT/EP1995/002978 WO1996004287A1 (fr) | 1994-07-29 | 1995-07-26 | Tetrahydropyridine-(ou 4-hydroxypiperidine) alkylazoles ayant une activite pour les recepteurs sigma et/ou 5ht1a |
Publications (3)
Publication Number | Publication Date |
---|---|
NO961207D0 true NO961207D0 (no) | 1996-03-25 |
NO961207L NO961207L (no) | 1996-05-29 |
NO309379B1 NO309379B1 (no) | 2001-01-22 |
Family
ID=9465902
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO961207A NO309379B1 (no) | 1994-07-29 | 1996-03-25 | Tetrahydropyridin-(eller 4-hydroksypiperidin)-alkylazoler som har affinitet for sigma og/eller 5HT1A-reseptorer |
Country Status (22)
Country | Link |
---|---|
US (2) | US5731331A (no) |
EP (1) | EP0721455B9 (no) |
JP (2) | JP4035787B2 (no) |
KR (1) | KR100389785B1 (no) |
CN (1) | CN1120167C (no) |
AT (1) | ATE229530T1 (no) |
AU (1) | AU712479B2 (no) |
BR (1) | BR9506292A (no) |
CA (1) | CA2172986A1 (no) |
CZ (1) | CZ293123B6 (no) |
DE (1) | DE69529142T2 (no) |
DK (1) | DK0721455T3 (no) |
FI (1) | FI116386B (no) |
FR (1) | FR2723091B1 (no) |
HU (1) | HU220088B (no) |
NO (1) | NO309379B1 (no) |
NZ (1) | NZ291172A (no) |
PL (1) | PL183766B1 (no) |
PT (1) | PT721455E (no) |
RU (1) | RU2168507C2 (no) |
WO (1) | WO1996004287A1 (no) |
ZA (1) | ZA956314B (no) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2723091B1 (fr) * | 1994-07-29 | 1996-11-08 | Esteve Labor Dr | Tetrahydropyridine-(6,4-hydroxypiperidine) alkylazoles |
FR2742052B1 (fr) * | 1995-12-12 | 1998-04-10 | Esteve Labor Dr | Utilisation des derives 1-(4-(4-aryl (ou heteroaryl)-1-piper azinyl)-buty)-1h-azole pour le traitement de la depression, des troubles obsessifs compulsifs, l'apnee du sommeil, les dysfonctions sexuelles, l'emese et le mal des transports |
GB9613423D0 (en) * | 1996-06-26 | 1996-08-28 | Lilly Industries Ltd | Pharmaceutical compounds |
HUP9602763A3 (en) * | 1996-10-09 | 1999-05-28 | Egyt Gyogyszervegyeszeti Gyar | 3-phenyl isoxazole derivatives, process for producing them and pharmaceutical compositions containing the same |
US5919802A (en) * | 1997-12-05 | 1999-07-06 | Princeton University | Methods of preventing and/or treating temporal lobe epilepsy |
ES2151828B1 (es) * | 1998-07-10 | 2001-08-16 | Esteve Labor Dr | Empleo de derivados de tetrahidropiridinas (ohidroxi-piperidinas)-b utilazoles en la elaboracion de un medicamento para el tratamiento del dolor. |
US6046331A (en) * | 1998-12-17 | 2000-04-04 | Synaptic Pharmaceutical Corporation | Imidazolones and their use in treating benign prostatic hyperplasia and other disorders |
GB2355456A (en) | 1999-09-30 | 2001-04-25 | Merck & Co Inc | Novel arylhydantoin derivatives useful as alpha 1a adrenoceptor antagonists |
UA73981C2 (en) * | 2000-03-10 | 2005-10-17 | Merck Patent Gmbh | (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treatment of extrapyramidal movement disorders (variants), pharmaceutical composition and kit |
DE10109866A1 (de) * | 2001-03-01 | 2002-09-05 | Abbott Gmbh & Co Kg | Triazolverbindungen und deren Verwendung zur Prophylaxe und Therapie neurodegenerativer Erkrankungen, Hirntrauma und zerebraler Ischämie |
DE10109867A1 (de) * | 2001-03-01 | 2002-09-05 | Abbott Gmbh & Co Kg | Verwendung von Triazolverbindungen zur Prophylaxe und Therapie neurodegenerativer Erkrankungen, Hirntrauma und zerebraler Ischämie |
ES2251316B1 (es) * | 2004-10-14 | 2007-03-16 | Laboratorios Del Dr. Esteve, S.A. | Inhibidores del receptor sigma. |
EP1781619B1 (en) | 2004-08-27 | 2011-08-17 | Laboratorios Del Dr. Esteve, S.A. | Sigma receptor inhibitors |
EP1634873A1 (en) | 2004-08-27 | 2006-03-15 | Laboratorios Del Dr. Esteve, S.A. | Sigma receptor inhibitors |
ES2251317B1 (es) * | 2004-10-14 | 2007-03-16 | Laboratorios Del Dr. Esteve, S.A. | Inhibidores del receptor sigma. |
KR100893394B1 (ko) * | 2007-05-11 | 2009-04-17 | 한국화학연구원 | 아릴 피페리딘기-함유 이미다졸 유도체, 이의 제조방법 및이를 유효성분으로 포함하는 약학적 조성물 |
KR100871077B1 (ko) * | 2007-05-11 | 2008-11-28 | 한국화학연구원 | 아릴 피페리딘기-함유 이미다졸 유도체, 이의 제조방법 및이를 유효성분으로 포함하는 약학적 조성물 |
JP5514716B2 (ja) * | 2007-05-11 | 2014-06-04 | コリア・リサーチ・インスティテュート・オブ・ケミカル・テクノロジー | アリールピペリジン置換基を有するイミダゾール誘導体、その製造方法及びこれを含む医薬組成物 |
KR100895998B1 (ko) * | 2007-05-11 | 2009-05-07 | 한국화학연구원 | 아릴 피페리딘기-함유 이미다졸 유도체, 이의 제조방법 및이를 유효성분으로 포함하는 약학적 조성물 |
SG10201510665WA (en) | 2009-12-04 | 2016-01-28 | Sunovion Pharmaceuticals Inc | Multicycle Compounds And Pharmaceutical Compositions Useful For The Treatment Of Neurological Disorders |
IL264446B1 (en) | 2016-07-29 | 2024-05-01 | Pgi Drug Discovery Llc | Compounds and compositions and their use |
MA45795A (fr) | 2016-07-29 | 2019-06-05 | Sunovion Pharmaceuticals Inc | Composés et compositions, et utilisations associées |
IL268694B2 (en) | 2017-02-16 | 2023-10-01 | Sunovion Pharmaceuticals Inc | Treatment of schizophrenia |
CN109280030B (zh) * | 2017-07-19 | 2022-04-22 | 江苏恩华药业股份有限公司 | 苯骈氮杂烷基芳基哌嗪衍生物及在制备药物中的应用 |
BR112020001433A2 (pt) | 2017-08-02 | 2020-07-28 | Sunovion Pharmaceuticals Inc. | compostos de isocromano e usos dos mesmos |
KR20200122345A (ko) | 2018-02-16 | 2020-10-27 | 선오비온 파마슈티컬스 인코포레이티드 | 염, 결정 형태 및 이들의 제조 방법 |
CA3130849A1 (en) | 2019-03-14 | 2020-09-17 | Sunovion Pharmaceuticals Inc. | Salts of a isochromanyl compound and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereof |
KR20230003503A (ko) | 2020-04-14 | 2023-01-06 | 선오비온 파마슈티컬스 인코포레이티드 | 신경학적 및 정신의학적 장애의 치료를 위한 (S)-(4,5-디히드로-7H-티에노[2,3-c]피란-7-일)-N-메틸메탄아민 |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3509153A (en) * | 1967-03-24 | 1970-04-28 | Miles Lab | 5-phenyl (or 5-phenylalkyl)-2-(omega-(4-phenyl-1-piperazinyl)alkyl)tetrazoles |
US3647790A (en) * | 1969-04-08 | 1972-03-07 | American Home Prod | Ouinoxalinyl-oxazolidines and -oxazines |
ES378315A1 (es) * | 1969-04-11 | 1972-06-01 | Robins Co Inc A H | Un procedimiento para la preparacion de 1 - (omega-susti- tuido-alcohil)-2-metilbenzimidazoles. |
JPS5011395B1 (no) * | 1970-12-29 | 1975-04-30 | ||
NZ181256A (en) * | 1975-07-21 | 1978-04-28 | Janssen Pharmaceutica Nv | 1-(w-benzazol-11-ylalkyl)-piperidine derivatives and pharmaceutical compositions containing certain of these derivatives |
US3981881A (en) * | 1975-08-14 | 1976-09-21 | E. R. Squibb & Sons, Inc. | 2-[(4-Phenyl-tetrahydropyridinyl)alkyl]-1H-isoindole-1,3(2H)-diones |
US3994904A (en) * | 1976-03-08 | 1976-11-30 | Miles Laboratories, Inc. | 3-Substituted -5-phenyl-5-pyridyl hydantoins |
JPS5746983A (en) * | 1980-09-04 | 1982-03-17 | Eisai Co Ltd | Theophylline derivative and its preparation |
JPS58150511A (ja) * | 1982-03-02 | 1983-09-07 | Eisai Co Ltd | テオフイリン誘導体を有効成分とする脳循環代謝改善剤 |
DE3307395A1 (de) * | 1982-03-02 | 1983-09-08 | Eisai Co., Ltd., Tokyo | Arzneimittel zur behandlung von schmerzen, fieber, gewebe- und/oder knochen- und gelenkentzuendungen mit einem gehalt an theobromin- oder theophyllinderivaten als aktivem bestandteil |
US4539407A (en) * | 1983-12-13 | 1985-09-03 | American Home Products Corporation | β-Carboline anticonvulsants |
US4675403A (en) * | 1985-10-16 | 1987-06-23 | American Home Products Corporation | 3-Aminoalkyl derivatives of 5,5-disubstituted hydantoins with psychotropic activity |
US4754038A (en) * | 1987-02-26 | 1988-06-28 | American Home Products Corporation | Carboline histamine H1 antagonists |
US5296487A (en) * | 1990-01-02 | 1994-03-22 | Fujisawa Pharmaceutical Co., Ltd. | Quinazoline derivatives and their preparation |
EP0436157B1 (en) * | 1990-01-02 | 1995-08-23 | Fujisawa Pharmaceutical Co., Ltd. | Quinazoline derivatives and their preparation |
FR2672052B1 (fr) * | 1991-01-28 | 1995-05-24 | Esteve Labor Dr | Derives d'aryl (ou heteroaryl)-piperazinyl-alkyl-azoles, leur preparation et leur application en tant que medicaments. |
JP3198117B2 (ja) * | 1990-02-07 | 2001-08-13 | サントリー株式会社 | ピロロアゼピン誘導体 |
US5149817A (en) * | 1990-03-05 | 1992-09-22 | Shionogi & Co., Ltd. | Teirahydropyridine derivatives |
JPH04211059A (ja) * | 1990-03-05 | 1992-08-03 | Shionogi & Co Ltd | 新規なテトラヒドロピリジン誘導体 |
FR2671972B1 (fr) * | 1991-01-25 | 1995-03-03 | Esteve Labor Dr | Utilisation de derives 1-h-azole-(omega-(4-(2-pyrimidinyl)-1-piperazinyl)-alkyl) pour la preparation de medicaments destines au traitement des troubles des fonctions cognitives. |
FR2673628B1 (fr) * | 1991-03-07 | 1993-07-09 | Esteve Labor Dr | Procede de preparation de derives d'aryl (ou heteroaryl)-piperazinyl-butyl-azoles. |
JP3219281B2 (ja) * | 1991-04-03 | 2001-10-15 | 聰 竹尾 | 心筋保護剤 |
DK148392D0 (da) * | 1992-12-09 | 1992-12-09 | Lundbeck & Co As H | Heterocykliske forbindelser |
JPH09505029A (ja) * | 1993-07-19 | 1997-05-20 | 藤沢薬品工業株式会社 | ドパミン受容体作動薬、5−HT受容体拮抗薬あるいはα▲下1▼受容体拮抗薬として有用なベンズイミダゾール誘導体 |
US5411960A (en) * | 1993-12-09 | 1995-05-02 | Bayer Aktiengesellschaft | Substituted pyrroloanthracenes and -diones |
FR2723091B1 (fr) * | 1994-07-29 | 1996-11-08 | Esteve Labor Dr | Tetrahydropyridine-(6,4-hydroxypiperidine) alkylazoles |
-
1994
- 1994-07-29 FR FR9409443A patent/FR2723091B1/fr not_active Expired - Fee Related
-
1995
- 1995-06-07 US US08/473,066 patent/US5731331A/en not_active Expired - Lifetime
- 1995-07-26 CN CN95190813A patent/CN1120167C/zh not_active Expired - Fee Related
- 1995-07-26 JP JP50617496A patent/JP4035787B2/ja not_active Expired - Fee Related
- 1995-07-26 EP EP95928478A patent/EP0721455B9/fr not_active Expired - Lifetime
- 1995-07-26 DE DE69529142T patent/DE69529142T2/de not_active Expired - Lifetime
- 1995-07-26 AU AU32225/95A patent/AU712479B2/en not_active Ceased
- 1995-07-26 CA CA002172986A patent/CA2172986A1/fr not_active Abandoned
- 1995-07-26 RU RU96110883/04A patent/RU2168507C2/ru not_active IP Right Cessation
- 1995-07-26 WO PCT/EP1995/002978 patent/WO1996004287A1/fr active IP Right Grant
- 1995-07-26 AT AT95928478T patent/ATE229530T1/de not_active IP Right Cessation
- 1995-07-26 NZ NZ291172A patent/NZ291172A/en unknown
- 1995-07-26 HU HU9600815A patent/HU220088B/hu not_active IP Right Cessation
- 1995-07-26 PL PL95313716A patent/PL183766B1/pl not_active IP Right Cessation
- 1995-07-26 BR BR9506292A patent/BR9506292A/pt not_active IP Right Cessation
- 1995-07-26 PT PT95928478T patent/PT721455E/pt unknown
- 1995-07-26 DK DK95928478T patent/DK0721455T3/da active
- 1995-07-26 CZ CZ1996926A patent/CZ293123B6/cs not_active IP Right Cessation
- 1995-07-26 KR KR1019960701606A patent/KR100389785B1/ko not_active IP Right Cessation
- 1995-07-28 ZA ZA956314A patent/ZA956314B/xx unknown
-
1996
- 1996-03-25 NO NO961207A patent/NO309379B1/no unknown
- 1996-03-28 FI FI961412A patent/FI116386B/fi not_active IP Right Cessation
-
1998
- 1998-02-26 US US09/031,024 patent/US6232329B1/en not_active Expired - Fee Related
-
2006
- 2006-09-27 JP JP2006290515A patent/JP2007051154A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO961207D0 (no) | Tetrahydropyridin-(eller 4-hydroksypiperidin)-alkylazoler som har affinitet for sigma og/eller 5HT1A-reseptorer | |
DE60224404D1 (de) | Substiuierte piperidine als melanocortinrezeptor-modulatoren | |
NO20051871L (no) | Opioidreseptorantagonister | |
DE69318854T2 (de) | Spiroazacyclischderivate als substanz p antagonisten | |
DK0841928T3 (da) | Sustained release-formulering af d-threo-methylphenidat | |
ATE108453T1 (de) | Benzopyridopiperidin, -piperidyliden und - piperazin-verbindungen, zusammensetzungen, methoden zur herstellung und verwendung. | |
ATE248852T1 (de) | Sterolderivate für die regulierung der meiose | |
PT923554E (pt) | N-benzilpiperidina e derivados tetrahidropiridina | |
NO20044764L (no) | 1-(aminoalkyl)-3-sulfonylindol og -indazolderivater som 5-hydroksytryptamin-6 ligander | |
NO20052172D0 (no) | 4-aminopiperidinderivater, fremgangsmate for deres fremstilling og deres anvendelse som medikamenter | |
ATE397599T1 (de) | Als modulatoren der chemokinrezeptoraktivität geeignete piperidinderivate | |
HUP0000756A2 (hu) | Levobupivakain vagy ropivakain alkalmazása migrén kezelésére alkalmas gyógyszerkészítmények előállítására | |
NO983860L (no) | Nye triazolopuriner, fremgangsmÕte for deres fremstilling og deres anvendelse som legemidler | |
NO904135L (no) | Fremgangsmaate for fremstilling av nye substituerte alkylpiperidiner og deres anvendelse som inhibitorer av kolesterolsyntese. | |
AU7695596A (en) | Use of 1-hydroxy-2-pyridones for treating mucosa diseases which are difficult to treat | |
ES2117934A1 (es) | Tetrahidropiridinas (0 4-hidroxipiperidinas) alquilazoles. | |
DE69428127D1 (de) | Schädlingsbekämpfungsmittel |